Showing results (541-550 of 562) with videos related to
Sort By:
Pageof 57
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Being ready to treat Ebola virus disease patientsDavid M Brett-Major, Shevin T Jacob, Frederique A Jacquerioz, et al.Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.The New England Journal of Medicine|September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous PolyposisCarol A Burke, Evelien Dekker, Patrick Lynch, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Dawn Provenzale, Xavier Llor, et al.Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Colorectal Cancer Screening, Version 1.2015Dawn Provenzale, Kory Jasperson, Dennis J Ahnen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017Samir Gupta, Dawn Provenzale, Scott E Regenbogen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018Dawn Provenzale, Samir Gupta, Dennis J Ahnen, et al.Trials|January 5, 2020
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.Pageof 57